Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Surgical Pathology

• Publication date

  2007-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/01.pas.0000213335.40358.47PMID 17255760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Fallopian Tube and Broad Ligament

  2008cited by this paper
• A candidate precursor to serous carcinoma that originates in the distal fallopian tube (J Pathol 2007; 211: 26–35)

  2007cited by this paper
• Tumours of the Fallopian tube

  2007cited by this paper
• Locus-specific mutation databases: pitfalls and good practice based on the p53 experience

  2006cited by this paper
• The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome

  2006cited by this paper
• Advances in the Recognition of Tubal Intraepithelial Carcinoma: Applications to Cancer Screening and the Pathogenesis of Ovarian Cancer

  2006cited by this paper
• Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

  2006cited by this paper
• Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With Immunohistochemical Correlation

  2005cited by this paper
• Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high‐grade carcinomas support different pathogenetic pathways

  2005cited by this paper
• A BRIEF COMMUNICATION

  2005cited by this paper
• Age-specific ovarian cancer incidence rate patterns in the United States.

  2005influential reference
• Initial Endometriosis Showing Direct Morphologic Evidence of Metaplasia in the Pathogenesis of Ovarian Endometriosis

  2005cited by this paper
• BRCA-Mutation–Associated Fallopian Tube Carcinoma: A Distinct Clinical Phenotype?

  2005influential reference
• Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

  2005cited by this paper
• Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.

  2004cited by this paper
• Histopathology, FIGO Stage, and BRCA Mutation Status of Ovarian Cancers from the Gilda Radner Familial Ovarian Cancer Registry

  2004cited by this paper
• Challenges in the Early Diagnosis and Staging of Fallopian-Tube Carcinomas Associated with BRCA Mutations

  2003cited by this paper
• Allelotype of papillary serous peritoneal carcinomas.

  2001cited by this paper
• Occult Carcinoma in Prophylactic Oophorectomy Specimens: Prevalence and Association With BRCA Germline Mutation Status

  2001cited by this paper
• Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis.

  2000cited by this paper
• Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation.

  2000cited by this paper
• Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes

  2000cited by this paper
• A high frequency of sequence alterations is due to formalin fixation of archival specimens.

  1999cited by this paper
• Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.

  1998cited by this paper
• Tumors of the Fimbriated End of the Fallopian Tube: A Clinicopathologic Analysis of 20 Cases, Including Nine Carcinomas

  1997cited by this paper
• Pathology of ovarian cancer precursors

  1995cited by this paper
• Early de novo ovarian carcinoma. A study of fourteen cases

  1994cited by this paper
• Cancer of the ovary.

  1994cited by this paper
• Cancer of the ovary.

  1993cited by this paper
• Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas.

  1993cited by this paper
• Incidence of malignant fallopian tube tumors.

  1989influential reference
• Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases

  1989cited by this paper

• Radiology-based artificial intelligence for predicting targeted therapy response in pan-cancer: a comprehensive review

  2025cites this paper
• Ovarian Carcinomas

  2025cites this paper
• Attitudes towards opportunistic salpingectomy among patients planned to undergo non-gynecologic intra-abdominal surgery

  2025cites this paper
• Epidemiología de los tumores de ovario

  2025cites this paper
• Development and Application of MiMouse, a Comprehensive Genomic Profiling Panel for Credentialing Mouse Tumor Models

  2025cites this paper
• Serous tubal intraepithelial carcinoma—looking into the earliest events of ovarian cancer development

  2025cites this paper
• Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures.

  2025cites this paper
• The potential for opportunistic salpingectomy to reduce ovarian cancer in women undergoing non-gynecologic surgery

  2025cites this paper
• Cancer of the ovary, fallopian tube, and peritoneum: 2025 update

  2025cites this paper
• Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube

  2025cites this paper
• Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma

  2025cites this paper
• Ursodeoxycholic acid prompts glycolytic dominance, reductive stress and epithelial-to-mesenchymal transition in ovarian cancer cells through NRF2 activation

  2025cites this paper
• Efficient profiling of total RNA in single cells with STORM-seq

  2025cites this paper
• [Is there a place for prophylactic fimbriectomy followed by delayed ovariectomy?]

  2025cites this paper
• The Typical Computed Tomography Findings of Primary Fallopian Tube Carcinoma.

  2025cites this paper
• Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study

  2025cites this paper
• Impact of Olaparib, Niraparib, Rucaparib therapies on Newly Diagnosed and Relapsed Ovarian Cancer -Systematic Review and Meta-Analysis

  2025cites this paper
• Pathology results of risk‐reducing salpingo‐oophorectomy in BRCA1/2 carriers and long‐term clinical outcomes

  2025cites this paper
• Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer

  2025cites this paper
• Épidémiologie des tumeurs de l’ovaire

  2025cites this paper
• Extensive Foamy Cell Change in Serous Tubal Intraepithelial Carcinoma and Tubal High-grade Serous Carcinoma.

  2025cites this paper
• Ectopic Pregnancy with a Normally Located Levonorgestrel-Releasing Intrauterine System in a Woman with Adenomyosis: Case Report and Literature Review

  2025cites this paper
• Circular RNAs as biomarkers and targets in ovarian cancer.

  2025cites this paper
• ZNF217 promotes ovarian cancer progression by impacting multiple pivotal steps in the metastatic process

  2025cites this paper
• Opportunistic salpingectomy during radical cystectomy for bladder cancer: A systematic review of the literature

  2025cites this paper
• Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-Grade Serous Tumors with Histologic Transformation.

  2025cites this paper
• Redefining Risk, Biomarkers, and Precision Therapy for Hereditary Ovarian Cancer: A Review

  2025cites this paper
• Molecular Diagnostics in Ovarian Cancer: Position Statement of the Interregional Organization of Molecular Geneticists in Oncology and Oncohematology

  2025cites this paper
• Distinct origins of high-grade serous ovarian carcinoma: genetic and epigenetic evidence linking ovarian and fallopian tube epithelium to clinical outcomes and early detection

  2025cites this paper
• Patients' Perspectives on Opportunistic Salpingectomy at the Time of Nongynecologic Surgery

  2025cites this paper
• Rete Ovarii Epithelial Cells as an Unappreciated Cell of Origin for Pelvic and Ovarian High-Grade Serous Carcinoma

  2025cites this paper
• Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets

  2025cites this paper
• Utility of Fallopian Tube Brush Cytology and Cell Blocks as a Screening Tool for Epithelial Ovarian Cancer in Patients Undergoing Gynaecological Surgeries for Benign and Malignant Indications: Attempt at a Classification System

  2025cites this paper
• Three Cases of Serous Tubal Intraepithelial Lesions (STILs)

  2024cites this paper
• Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery

  2024cites this paper
• Optimization of Timing for Risk-Reducing Salpingectomy and Oophorectomy.

  2024cites this paper
• Ovarian carcinomas: clinicopathological and molecular characteristics. Comments on the 2014 FIGO staging system

  2024cites this paper
• The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions.

  2024cites this paper
• Single-cell transcriptome analysis reveals reciprocal epithelial and endothelial cell evolution in ovarian cancer

  2024cites this paper
• Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma

  2024cites this paper
• Association of human papillomavirus 16 and 18 with ovarian cancer risk: Insights from a meta‑analysis

  2024cites this paper
• Current Science and Practice of Surgical and Nonsurgical Opportunities for Ovarian Cancer Prevention

  2024cites this paper
• Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Urogynecological Surgery: A Systematic Review

  2024cites this paper
• Early genetic divergence of high-grade carcinomas originating from low-grade ovarian serous neoplasms.

  2024cites this paper
• Fallopian Tube-Derived High-Grade Serous Cancers Influence Ovarian Production of Norepinephrine and Generate Specific Metabolomic Signatures.

  2024cites this paper
• Ovarian/Tubal Pathology in Premenopausal Women with Breast Cancer: A Prospective Study

  2024cites this paper
• Ovarian neoplasms in pediatric gynecology (literature review)

  2024cites this paper
• Liposomic nano particles in the treatment of colorectal and ovarian cancer

  2024cites this paper
• High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report

  2024cites this paper
• Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma

  2024cites this paper
• Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells

  2024cites this paper
• BRCA Mutation Patients: Are There Other Predisposing Factors for Ovarian Cancer Occurrence? A Multicenter Retrospective Study

  2024cites this paper
• A Young Girl with Recurrent Fallopian Tube Carcinoma (FTC): An Interesting Case Report

  2024cites this paper
• Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design

  2024cites this paper
• PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials

  2024cites this paper
• Macroscopic examination of gynaecological specimens: a critial and often underemphasised aspect of pathological reporting

  2024cites this paper
• Recurrence Rate and Associated Factors of Primary Fallopian Tube Carcinoma in the South of Vietnam

  2024cites this paper
• From fallopian tube epithelium to high-grade serous ovarian cancer: A single-cell resolution review of sex steroid hormone signaling.

  2024cites this paper
• Molecular Pathology of Ovarian Epithelial Neoplasms: Predictive, Prognostic, and Emerging Biomarkers.

  2024cites this paper
• Integrative Strategies for Ovarian Cancer Treatment: A Comprehensive Review from Ayush Perspectives

  2024cites this paper
• PREVENTION OF OVARIAN, FALLOPIAN TUBE, AND PERITONEAL SEROUS CANCERS (LITERATURE REVIEW)

  2024cites this paper
• Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma

  2024cites this paper
• Ultra-radical surgery versus standard-radical surgery for the primary cytoreduction of advanced epithelial ovarian cancer; long-term tertiary center experiences.

  2024cites this paper
• Serous tubal intraepithelial carcinoma and management after its incidental finding

  2024cites this paper
• Salpingectomy for ectopic pregnancy reduces ovarian cancer risk—a nationwide study

  2024cites this paper
• Single-cell transcriptome analysis of epithelial, immune, and stromal signatures and interactions in human ovarian cancer

  2024cites this paper
• Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany

  2023influential citation
• The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives

  2023cites this paper
• Postpartum Opportunistic Salpingectomy Compared With Bilateral Tubal Ligation After Vaginal Delivery for Ovarian Cancer Risk Reduction

  2023cites this paper
• Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review

  2023cites this paper
• High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors

  2023influential citation
• Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view

  2023cites this paper
• Expression Of Hippo-YAP Signaling Pathway in Gynecological Tumors

  2023cites this paper
• Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study

  2023cites this paper
• Disparity in the era of personalized medicine for epithelial ovarian cancer

  2023cites this paper
• Prise en charge chirurgicale des cancers de l’ovaire de stade avancé après chimiothérapie néoadjuvante étude retrospective comparant la prise en charge chirurgicale après 3 cycles ou plus

  2023cites this paper
• Profiling extracellular vesicles in circulation enables the early detection of ovarian cancer

  2023cites this paper
• Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review

  2023cites this paper
• Dichotomous ovarian cancer-initiating potential of Pax8+ cells revealed by a mouse genetic mosaic model

  2023cites this paper
• Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer.

  2023cites this paper
• Carcinoma Endometrioid Ovary pada Struma Ovarii

  2023cites this paper
• Complications following Opportunistic Salpingectomy compared to Tubal Ligation at cesarean delivery: A retrospective cohort study.

  2023cites this paper
• Opportunistic salpingectomy between 2017 and 2020: A descriptive analysis.

  2023cites this paper
• Utilitatea salpingectomiei profilactice – prezentare de caz

  2023cites this paper
• Incessant ovulation: a review of its importance in predicting cancer risk

  2023cites this paper
• Complete Compared With Partial Salpingectomy for Postpartum Sterilization

  2023cites this paper
• Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis

  2023cites this paper
• Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas

  2023cites this paper
• Cellular Origins and Lineage Plasticity in Cancer.

  2023cites this paper
• Molecular biomarkers for facilitating genome‑directed precision medicine in gynecological cancer (Review)

  2023cites this paper
• Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.

  2023cites this paper
• Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection

  2023cites this paper
• Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma

  2023cites this paper
• Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer

  2023cites this paper
• The Validation of a Precursor Lesion of Epithelial Ovarian Cancer in Fancd2-KO Mice

  2023cites this paper
• Concept of opportunistic bilateral salpingectomy in a sample of Mexican gynecologists. What should residents be trained on?

  2023cites this paper
• Expression of low-sulfated keratan sulfate in non-mucinous ovarian carcinoma.

  2023cites this paper
• Primary Retroperitoneal Carcinomas: New Insights into Pathogenesis and Clinical Management in Comparison with Ovarian Carcinomas and Carcinoma of Unknown Primary

  2023cites this paper
• Gain-of-function p53R175H blocks apoptosis in a precursor model of ovarian high-grade serous carcinoma

  2023cites this paper
• Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer

  2022cites this paper